- Filed
- Aug 11, 2017 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2017 · Aug 10, 2017 | 147.89M sh |
| Stockholders Equity | Q2 2017 · Jun 30, 2017 | −$18.19M |
| Stockholders Equity | Q2 2017 · Dec 31, 2015 | −$21.42M |
| Current Liabilities | Q2 2017 · Jun 30, 2017 | $14.04M |
| Current Liabilities | Q2 2017 · Dec 31, 2016 | $16.61M |
| Total Liabilities | Q2 2017 · Jun 30, 2017 | $25.3M |
| Total Liabilities | Q2 2017 · Dec 31, 2016 | $29.26M |
| Current Assets | Q2 2017 · Jun 30, 2017 | $6.35M |
| Current Assets | Q2 2017 · Dec 31, 2016 | $7.27M |
| Total Assets | Q2 2017 · Jun 30, 2017 | $7.11M |
| Total Assets | Q2 2017 · Dec 31, 2016 | $8.13M |
| Net Income | Q2 2017 · Jun 30, 2017 | $2.68M |
| Net Income | Q2 2017 · Dec 31, 2016 | $101.88K |
| Net Income | Q2 2017 · Jun 30, 2016 | −$2M |
| Net Income | Q2 2017 · Jun 30, 2016 | −$2.87M |
| Shares Diluted | Q2 2017 · Jun 30, 2016 | 146.98M sh |
| Shares Diluted | Q2 2017 · Jun 30, 2016 | 144.03M sh |
| Capex | Q2 2017 · Jun 30, 2016 | $164.45K |
| Cash And Equivalents | Q2 2017 · Jun 30, 2016 | $857.1K |
| Cash And Equivalents | Q2 2017 · Dec 31, 2015 | $835.22K |
| Eps Diluted | Q2 2017 · Jun 30, 2016 | −$0.01 |
| Eps Diluted | Q2 2017 · Jun 30, 2016 | −$0.02 |
| Eps Basic | Q2 2017 · Jun 30, 2016 | −$0.01 |
| Eps Basic | Q2 2017 · Jun 30, 2016 | −$0.02 |
| Sga Expense | Q2 2017 · Jun 30, 2016 | $441.72K |
| Sga Expense | Q2 2017 · Jun 30, 2016 | $824.78K |
| Rd Expense restated | Q2 2017 · Jun 30, 2016 | $1.32M |
| Operating Income | Q2 2017 · Jun 30, 2016 | $31.86K |
| Operating Income | Q2 2017 · Jun 30, 2016 | $206.26K |
| Gross Profit | Q2 2017 · Jun 30, 2016 | $3.93M |
| Gross Profit | Q2 2017 · Jun 30, 2016 | $7.91M |
| Revenue | Q2 2017 · Jun 30, 2016 | $5.3M |
| Revenue | Q2 2017 · Jun 30, 2016 | $10.46M |